Related Blog Posts
SNSS, STEM, PWRM, SNY CRWEPicks Stock Report! 12/11/2009 | Free Stock Tips
4 hours ago ago from Free Stock Tips offers a free stock newsletter
*********************************** Sunesis Presents Positive Phase 2 Clinical Data of Voreloxin in Acute Myeloid Leukemia at the American Society of Hematology 2009 Annual Meeting Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) today announced positive data from two Phase 2 clinical trials of the Company's lead drug candidate, voreloxin. The results highlight voreloxin's strong efficacy and safety profile when used as a single agent or ...
Related contentVirgin Airlines likely to land at O’Hare
3 hours ago ago from Chicago Multi Family Real Estate
(AP) — Virgin America Inc. is eyeing Chicago as the British carrier looks to expand its service next year. The airline’s Chief Executive Officer David Cush said in an interview that he will probably launch service to O’Hare Airport from Los Angeles and San Francisco as part of an ...
Related contentHas anyone heard of the CCP Group Management Development Programme? And are they for real or is it a scam?
9 hours ago ago from Powersports Management
I have been approached by this company through Monster.com who said they found my CV and wish to offer me the opportunity to train and work as a manager, I haven't heard of them so need some advice on whether they are for real. Any help greatly appreciated. With information technology (IT) at the heart of company operations and the biggest driver underpinning new business opportunities these days, chief information officers must ...
Related contentSTEM, PWRM, SNY Stock-PR.com Reporting Dec. 11, 2009
6 hours ago ago from Marketing Tools
Stock-PR Reporting STEM, PWRM, SNY FREE Daily Stock Alerts From Stock-PR.com ________________________________________ StemCells, Inc. (NASDAQ: STEM) announced that it welcomes the approval yesterday by the National Institutes of Health (NIH) of the first 13 human embryonic stem cell (hESC) lines for use in NIH-funded research under the NIH Guidelines for Human Stem Cell Research adopted in July 2009. The ...
Related contentAfexa Life Sciences Inc., Maker of COLD-FX(R), Appoints Jack Moffatt as Chairman and Chief Executive Officer
21 hours ago ago from Stock News
EDMONTON, ALBERTA–(CRWE NEWSWIRE) - Afexa Life Sciences Inc. (”Afexa” or the “Company”) (TSX:FXA) Lead Director J. Douglas Gilpin today announced, on behalf of the Board of Directors, the appointment of Jack Moffatt as Chairman and Chief Executive Officer of the Company, effective immediately. In mid-2007, Mr. Moffatt became an advisor to Management and the Board of Directors of the Company. In September 2008 he was appointed to the ...
Related contentRelated News
A.I.G. General Counsel Is Set to Depart Amid Talks on Pay
19 hours ago ago from The New York Times
Tough negotiations with the government over how to compensate top executives of the American International Group have ended with the likely departure of the company's general counsel, according to people close to the talks. Recent developments on issues surrounding executive compensation with background, analysis, timelines and earlier events from NYTimes.com and Google. The general counsel, Anastasia D. Kelly, ...
Related contentUmpqua Bank Named Most Admired Financial Services Company in Oregon
22 hours ago ago from PopEater
Umpqua Bank, a subsidiary of Umpqua Holdings Corporation (NASDAQ:UMPQ) , was named the Most Admired Financial Services Company in Oregon today at The Portland Business Journal’s fifth annual Oregon’s Most Admired Companies luncheon. Additionally, the community bank was voted the fifth Most Admired Company across all industries, the only financial services company recognized overall. Umpqua Bank has been named Oregon’s Most Admired Financial ...
Related contentDollar Financial Corp. Announces Pricing of $600 Million 10⅜% Senior Notes
8 hours ago ago from PopEater
Dollar Financial Corp. (NASDAQ: DLLR), a leading international diversified financial services company primarily serving unbanked and under-banked consumers for nearly 30 years, today announced the pricing of the $600 million aggregate principal amount of senior notes offered by its indirect wholly owned Canadian subsidiary, National Money Mart Company. The notes will pay interest semi-annually at a rate of 10.375% per annum. The notes will be ...
Related contentDeltagen Acquires Benten BioServices
23 hours ago ago from PopEater
Deltagen, Inc. (Pink Sheets: DGEN), a leading provider of drug discovery and screening tools to the biopharmaceutical industry, today announced that it has acquired Benten BioServices, Inc. (“Benten”). Benten is an emerging Pennsylvania-based contract services organization developed to offer a comprehensive suite of regulatory-compliant manufacturing and testing services to support the development and commercialization of biopharmaceutical ...
Related contentMiller Nash Named One of Oregon’s Most Admired Companies
23 hours ago ago from PopEater
The Portland Business Journal and the Oregon business community have again named Miller Nash LLP one of the top professional services companies in the state. Miller Nash was ranked third Most Admired Professional Services Company for 2009 on the publication’s Most Admired Companies in Oregon list. The multiservice commercial law firm was recognized at an awards luncheon held today at Portland, Ore.’s Hilton Hotel. “Our firm’s first priority ...
Related contentRelated Videos
Nothing to see... move along.
